Concepedia

Vivek Shinde

VS

36

Publications

5.8K

Citations

27

H-Index

2009

Active since

Affiliations

Novavax (United States)(Current)

GlaxoSmithKline (Belgium)

Centers for Disease Control and Prevention

South African Medical Research Council

University of the Witwatersrand

Vivek Shinde is an author at Novavax (United States) specializing in medicine, vaccination, and vaccine development.

Top concepts

Publications per year

2009–2023

36

Publications

36

Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine

Cheryl Keech, Gary Albert, Iksung Cho et al. · New England Journal of Medicine · 2020 · 1.2K citations · Full text

Risk Factors for Severe Outcomes following 2009 Influenza A (H1N1) Infection: A Global Pooled Analysis

Maria D. Van Kerkhove, Katelijn Vandemaele, Vivek Shinde et al. · PLoS Medicine · 2011 · 711 citations · Full text

Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 Variant

Vivek Shinde, Sutika Bhikha, Zaheer Hoosain et al. · New England Journal of Medicine · 2021 · 652 citations · Full text

Triple-Reassortant Swine Influenza A (H1) in Humans in the United States, 2005–2009

Vivek Shinde, Carolyn B. Bridges, Timothy M. Uyeki et al. · New England Journal of Medicine · 2009 · 609 citations · Full text

Respiratory Syncytial Virus Vaccination during Pregnancy and Effects in Infants

Shabir A. Madhi, Fernando P. Polack, Pedro A. Piedra et al. · New England Journal of Medicine · 2020 · 408 citations · Full text

Rows per page

1–5 of 36